大众交通：子公司200万美元认购私募基金60.61%份额

Core Viewpoint - The company has signed a subscription agreement to invest $2 million in RealtimePlus Ltd., acquiring a 60.61% stake in the company, which focuses on the biopharmaceutical sector [1] Group 1: Investment Details - The investment is made by the company's wholly-owned subsidiary, Volkswagen Hong Kong [1] - The fund was established on July 31 with a total size of $3.3 million, targeting early-stage companies in the biopharmaceutical field [1] - This transaction does not constitute a related party transaction or a major asset restructuring, thus does not require board or shareholder approval [1] Group 2: Risks and Considerations - The investment has a long cycle, which may expose the company to liquidity risks [1] - Changes in macroeconomic policies could impact the operations of the invested companies and the value of the fund's targets [1]